Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary of global life sciences titan Bayer AG. Financial terms of the deal with ...
With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback